Next Article in Journal
Inside the Brain: Fragrance Effects on Human Attention
Previous Article in Journal
Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Improved “General Unknown” Drug Screening Using GCxGCqMS

1
Shimadzu Europa GmbH, Albert Hahn-Str. 6–10, 47269 Duisburg, Germany
2
MVZ für Mikrobiologie, Labordiagnostik und Hygiene Dessau GmbH, Bauhüttenstr. 6, 06847 Dessau, Germany
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 183; https://doi.org/10.3797/scipharm.oephg.21.SL-16
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009

Abstract

Drug screening in the clinical setting is very often started or even solely performed with a limited selection of enzyme immunoassays in urine samples. As a general rule positive results must be confirmed by more specific and sensitive methods like GC/MS or LC/MS(-MS). GC/MS full scan mode giving the highest level of specificity often faces the problem of co-elution which esp. at high concentrations cannot be circumvented even with modern deconvolution software in many cases. However, broad, undirected “general unknown” screening for drugs of abuse not covered by the EIA/GC/MS-SIM combinations is of increasing importance. In the present study we therefore investigated if the common drawbacks encountered in a standard GC/MS full-scan method could be improved by increased chromatographic resolution by means of comprehensive GCxqGCMS in full-scan mode [1]. To perform comprehensive GCxGC measurements a two stage loop modulator (ZOEX cooperation USA) was used. By use of a modulation frequency of 6 seconds together with the selected GC parameters results in 3 modulated peaks per compound. The results out of the comprehensive GCxGCqMS were compared with the one dimensional data set.

Share and Cite

MDPI and ACS Style

BÖHME, S.; BÖTTCHER, M. Improved “General Unknown” Drug Screening Using GCxGCqMS. Sci. Pharm. 2009, 77, 183. https://doi.org/10.3797/scipharm.oephg.21.SL-16

AMA Style

BÖHME S, BÖTTCHER M. Improved “General Unknown” Drug Screening Using GCxGCqMS. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):183. https://doi.org/10.3797/scipharm.oephg.21.SL-16

Chicago/Turabian Style

BÖHME, S., and M. BÖTTCHER. 2009. "Improved “General Unknown” Drug Screening Using GCxGCqMS" Scientia Pharmaceutica 77, Short Lectures (SL): 183. https://doi.org/10.3797/scipharm.oephg.21.SL-16

Article Metrics

Back to TopTop